Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PACS GroupPACS +4.53%19 EV-to-EBIT is 27.49 as of Jul. 25, 2026, which is 14% below its 10-year median of 31.90. GuruFocus rates PACS with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 469 Healthcare Providers & Services companies, PACS Group ranks worse than 72.71% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PACS Group's Enterprise Value for the quarter that ended in Mar. 2026 was $8,171 Mil.
PACS Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $383 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PACS Group EV-to-EBIT Related Terms
PACS Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for PACS Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PACS Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PACS Group EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PACS Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PACS Group's EV-to-EBIT falls into.
PACS Group's current Enterprise Value is $10,537 Mil.
PACS Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $383 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PACS Group (PACS) has a EV-to-EBIT of 27.49 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PACS Group and its competitors. This is 14% below median its historical median of 31.90. Over the past decade, PACS Group's EV-to-EBIT has ranged from 16.88 to 69.75. According to the industry distribution chart, PACS Group ranks #341 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 72.7%.
Is PACS Group's EV-to-EBIT too high?
PACS Group's current EV-to-EBIT of 27.49 is 14% below median its 10-year median of 31.90. Over the past 10 years, this metric has ranged from a low of 16.88 to a high of 69.75. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. PACS Group's value of 27.49 is 73.2% above this industry median. Based on the distribution chart, PACS Group ranks #341 out of 469 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PACS Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PACS Group's EV-to-EBIT compare to CHE and UHS?
According to the Healthcare Providers & Services industry distribution chart, PACS Group ranks #341 out of 469 companies for EV-to-EBIT. This places PACS Group in the lower half of its industry. The industry median EV-to-EBIT is 15.87. PACS Group's value of 27.49 is 73.2% above this benchmark. Historically, PACS Group's own EV-to-EBIT has ranged from 16.88 to 69.75 over the past decade. While the company's 10-year median is 31.90 vs. the industry median of 15.87, PACS Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PACS Group's current EV-to-EBIT of 27.49 is 73.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PACS Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PACS Group's current EV-to-EBIT is 27.49, which is 14% below median its own 10-year median of 31.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PACS Group stock overvalued right now?
PACS Group (PACS) has a current EV-to-EBIT of 27.49. The current EV-to-EBIT is 27.49, which is 14% below median its 10-year median of 31.90 and 73.2% above the Healthcare Providers & Services industry median of 15.87. PACS Group's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PACS Group (PACS), the current EV-to-EBIT is 27.49 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
19GF Score
Get the complete analysis for PACS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACS has been successfully added to your 
